GI Research Team, The Christie NHS Foundation Trust

Manchester M20 4BX

0 studies enrolling now · 1 studies all time

What they study most

BRAF V600E-mutant Metastatic Colorectal Cancer

Studies at this site

• Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer — Completed